SCHEMBL16201652

SCHEMBL16201652

CC(C)n1c2c(c3sccc31)CC(=O)N(C)C2=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16201669 0.78 KDM4E (0.32)
SCHEMBL16201642 0.75 TSHR (0.40)
SCHEMBL23312221 0.68 ALDH1A1 (0.39)
SCHEMBL16201657 0.68 TSHR (0.34)
SCHEMBL16201668 0.65 CSNK2A2 (0.34)
SCHEMBL16201670 0.64 PDE4B (0.31)
SCHEMBL16870185 0.61 CES1 (0.34)
SCHEMBL22175509 0.59 HPD (0.35)
SCHEMBL16201651 0.58 POLB (0.39)
SCHEMBL11998966 0.58 TRIM24 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9345905-B2 Heterocyclic amides compounds which are HDAC6 inhibitors and used as anti-tumoral agents NANJING ALLGEN PHARMA CO. LTD. (CN) 2016-05-24 US disclosed
US-20140322229-A1 HETEROCYCLIC AMIDES COMPOUNDS WHICH ARE HDAC6 INHIBITORS AND USED AS ANTI-TUMORAL AGENTS BETA PHARMA CANADA INC. (CA) 2014-10-30 US disclosed